{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T14:35:45Z","timestamp":1778769345527,"version":"3.51.4"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:00:00Z","timestamp":1618963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["por-journal.com"],"crossmark-restriction":true},"short-container-title":["Pathol. Oncol. Res."],"abstract":"<jats:p>Thymic epithelial tumors are the most common mediastinal tumors. Surgery is the mainstay of treatment and complete resection provides the best survival rate. However, advanced tumors often require multimodality treatment and thus we analyzed the prognostic potential of routine circulating biomarkers that might help to risk-stratify patients beyond tumor stage and histology. Preoperative values for white blood cell count (WBC), C-reactive protein (CRP) and lactate dehydrogenase (LDH) were analyzed in 220 thymic epithelial tumor patients operated between 1999 and 2018. Increased CRP levels (&amp;gt;1\u00a0mg\/dl) were significantly more often measured in thymic carcinoma and neuroendocrine tumors when compared to thymoma. LDH serum activity was higher in thymic neuroendocrine tumors when compared to thymoma or thymic carcinoma. The median disease specific survival was significantly longer in thymoma cases than in thymic carcinoma and neuroendocrine tumors. Increased preoperative LDH level (&amp;gt;240\u00a0U\/L) associated with shorter survival in thymus carcinoma (HR 4.76, <jats:italic>p<\/jats:italic> = 0.0299). In summary, higher CRP associated with carcinoma and neuroendocrine tumors, while LDH increased primarily in neuroendocrine tumors suggesting that biomarker analysis should be performed in a histology specific manner. Importantly, preoperative serum LDH might be a prognosticator in thymic carcinoma and may help to risk stratify surgically treated patients in multimodal treatment regimens.<\/jats:p>","DOI":"10.3389\/pore.2021.629993","type":"journal-article","created":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T04:12:54Z","timestamp":1618978374000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Potential Prognostic Value of Preoperative Leukocyte Count, Lactate Dehydrogenase and C-Reactive Protein in Thymic Epithelial Tumors"],"prefix":"10.3389","volume":"27","author":[{"given":"Daniel","family":"Valdivia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danjouma","family":"Cheufou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Fels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Puhlvers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khaled","family":"Mardanzai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Zaatar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Weinreich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Taube","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Theegarten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Stuschke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Schuler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Stamatis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Balazs","family":"Hegedus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clemens","family":"Aigner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1007\/s11748-014-0420-z","article-title":"Therapy for thymic epithelial tumors","volume":"62","author":"Kondo","year":"2014","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"B2","doi-asserted-by":"publisher","first-page":"96","DOI":"10.5306\/wjco.v6.i5.96","article-title":"New findings on thymic epithelial tumors: something is changing","volume":"6","author":"Berardi","year":"2015","journal-title":"World J Clin Oncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1097\/jto.0000000000000654","article-title":"The 2015 world health organization classification of tumors of the thymus: continuity and changes","volume":"10","author":"Marx","year":"2015","journal-title":"J Thorac Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1055\/s-0032-1322611","article-title":"Thymomas and thymic carcinomas: prognostic factors and multimodal management","volume":"62","author":"Moser","year":"2014","journal-title":"Thorac Cardiovasc Surg"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1200\/jco.2004.10.113","article-title":"Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis","volume":"22","author":"Str\u00f6bel","year":"2004","journal-title":"J Clin Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jtcvs.2014.08.061","article-title":"Outcome of primary neuroendocrine tumors of the thymus: a joint analysis of the international thymic malignancy interest group and the European society of thoracic surgeons databases","volume":"149","author":"Filosso","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B7","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/jto.0000000000000128","article-title":"Thymic carcinoma: a cohort study of patients from the European society of thoracic surgeons database","volume":"9","author":"Ruffini","year":"2014","journal-title":"J Thorac Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1093\/ejcts\/ezv086","article-title":"Surgical treatment of recurrent thymoma: is it worthwhile?","volume":"49","author":"Marulli","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"B9","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.athoracsur.2012.02.092","article-title":"The role of surgical management in recurrent thymic tumors","volume":"94","author":"Hamaji","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"B10","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1093\/icvts\/ivv144","article-title":"Is it valuable and safe to perform reoperation for recurrent thymoma?: Table 1:","volume":"21","author":"Dai","year":"2015","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1097\/jto.0b013e3182598a91","article-title":"Clinical outcomes and prognosis of recurrent thymoma management","volume":"7","author":"Bae","year":"2012","journal-title":"J Thorac Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1172\/jci200318921","article-title":"C-reactive protein: a critical update","volume":"111","author":"Pepys","year":"2003","journal-title":"J Clin Invest"},{"key":"B13","doi-asserted-by":"publisher","first-page":"47090","DOI":"10.18632\/oncotarget.17478","article-title":"Elevated CRP levels predict poor outcome and tumor recurrence in patients with thymic epithelial tumors: a pro- and retrospective analysis","volume":"8","author":"Janik","year":"2017","journal-title":"Oncotarget"},{"key":"B14","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/s0169-5002(00)00131-8","article-title":"Comparative prognostic value of lactate dehydrogenase and neuron-specific enolase in small-cell lung cancer patients treated with platinum-based chemotherapy","volume":"30","author":"Quoix","year":"2000","journal-title":"Lung Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e359","DOI":"10.1016\/j.ijrobp.2011.06.1967","article-title":"Baseline serum lactate dehydrogenase levels for patients treated with intensity-modulated radiotherapy for nasopharyngeal carcinoma: a predictor of poor prognosis and subsequent liver metastasis","volume":"82","author":"Zhou","year":"2012","journal-title":"Int J Radiat Oncology*Biology*Physics"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1054\/bjoc.1999.1140","article-title":"Pre-induction LDH as a prognostic factor for outcome of high dose chemotherapy (HDCT) for germ cell tumours relapsing or refractory to conventional chemotherapy","volume":"82","author":"Shamash","year":"2000","journal-title":"Br J Cancer"},{"key":"B17","doi-asserted-by":"publisher","first-page":"4550","DOI":"10.21037\/jtd.2017.10.86","article-title":"Elevated pretreatment serum lactate dehydrogenase level predicts inferior overall survival and disease-free survival after resection of thymic carcinoma","volume":"9","author":"Liu","year":"2017","journal-title":"J Thorac Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.21037\/jtd.2016.08.56","article-title":"Prognostic value of preoperative serum lactate dehydrogenase in thymic carcinoma","volume":"8","author":"Yuan","year":"2016","journal-title":"J Thorac Dis"},{"key":"B19","volume-title":"NCCN thymomas and thymic carcinomas (version 2.2016)","year":"2016"},{"key":"B20","doi-asserted-by":"publisher","first-page":"S88","DOI":"10.1097\/jto.0000000000000293","article-title":"The ITMIG\/IASLC thymic epithelial tumors staging project: a proposed lymph node map for thymic epithelial tumors in the forthcoming 8th edition of the TNM classification of malignant tumors","volume":"9","author":"Bhora","year":"2014","journal-title":"J Thorac Oncol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1002\/1097-0142(19811201)48:11<2485::aid-cncr2820481123>3.0.co;2-r","article-title":"Follow-up study of thymomas with special reference to their clinical stages","volume":"48","author":"Masaoka","year":"1981","journal-title":"Cancer"},{"key":"B22","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/j.1440-1827.1994.tb02936.x","article-title":"A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma","volume":"44","author":"Koga","year":"1994","journal-title":"Pathol Int"},{"key":"B23","author":"Travis","year":"2004"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.3892\/ijo.2014.2272","article-title":"Expression of microRNA-21 in non-small cell lung cancer tissue increases with disease progression and is likely caused by growth conditional changes during malignant transformation","volume":"44","author":"Haigl","year":"2014","journal-title":"Int J Oncol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"S1484","DOI":"10.21037\/jtd.2017.10.83","article-title":"Neuroendocrine tumors of the thymus","volume":"9","author":"Filosso","year":"2017","journal-title":"J Thorac Dis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/s0003-4975(98)01063-7","article-title":"Thymic neuroendocrine tumor (thymic carcinoid): a clinicopathologic study in 15 patients","volume":"67","author":"Fukai","year":"1999","journal-title":"Ann Thorac Surg"},{"key":"B27","doi-asserted-by":"publisher","first-page":"vii120","DOI":"10.1093\/annonc\/mds267","article-title":"Neuroendocrine bronchial and thymic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"23","author":"\u00d6berg","year":"2012","journal-title":"Ann Oncol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"S1491","DOI":"10.21037\/jtd.2017.08.18","article-title":"Neuroendocrine tumors of the thymus: the oncologist point of view","volume":"9","author":"Girard","year":"2017","journal-title":"J Thorac Dis"},{"key":"B29","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1177\/1556984520949287","article-title":"Thymic neuroendocrine tumors and thymic carcinoma: demographics, treatment, and survival","volume":"15","author":"Bakhos","year":"2020","journal-title":"Innovations (Phila)"},{"key":"B30","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.athoracsur.2016.07.050","article-title":"Neuroendocrine tumors of the thymus: analysis of factors affecting survival in 254 patients","volume":"103","author":"Sullivan","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"B31","doi-asserted-by":"publisher","first-page":"18581","DOI":"10.1038\/s41598-019-54906-4","article-title":"Clinical prognostic scores for patients with thymic epithelial tumors","volume":"9","author":"Veraar","year":"2019","journal-title":"Sci Rep"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1245\/s10434-020-08228-9","article-title":"High neutrophil count as a negative prognostic factor for relapse in patients with thymic epithelial tumor","volume":"27","author":"Okada","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"76099","DOI":"10.18632\/oncotarget.18546","article-title":"The correlation of neutrophil-to-lymphocyte ratio with the presence and activity of myasthenia gravis","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.21037\/jtd.2016.05.05","article-title":"Prognostic value of preoperative neutrophil-lymphocyte ratio is superior to platelet-lymphocyte ratio for survival in patients who underwent complete resection of thymic carcinoma","volume":"8","author":"Yuan","year":"2016","journal-title":"J Thorac Dis"},{"key":"B35","doi-asserted-by":"publisher","first-page":"21861","DOI":"10.18632\/oncotarget.25076","article-title":"Prognostic and diagnostic impact of fibrinogen, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio on thymic epithelial tumors outcome","volume":"9","author":"Janik","year":"2018","journal-title":"Oncotarget"},{"key":"B36","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s00595-017-1602-y","article-title":"Prognostic significance of the preoperative neutrophil-to-lymphocyte ratio for complete resection of thymoma","volume":"48","author":"Yanagiya","year":"2018","journal-title":"Surg Today"},{"key":"B37","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1136\/jnnp.48.8.757","article-title":"Myasthenia gravis: long-term prognostic value of thymus lactate dehydrogenase isoenzyme pattern of hyperplastic thymus and thymoma","volume":"48","author":"Szathmary","year":"1985","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e324","DOI":"10.1097\/md.0000000000000324","article-title":"Long-term follow-up and prognostic factors for advanced thymic carcinoma","volume":"93","author":"Wu","year":"2014","journal-title":"Medicine (Baltimore)"}],"container-title":["Pathology and Oncology Research"],"original-title":[],"link":[{"URL":"https:\/\/www.por-journal.com\/articles\/10.3389\/pore.2021.629993\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T14:47:24Z","timestamp":1626187644000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.por-journal.com\/articles\/10.3389\/pore.2021.629993\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,21]]},"references-count":38,"alternative-id":["10.3389\/pore.2021.629993"],"URL":"https:\/\/doi.org\/10.3389\/pore.2021.629993","relation":{},"ISSN":["1532-2807"],"issn-type":[{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,21]]},"article-number":"629993"}}